Curative Biotechnology, Inc.?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a development-stage biomedical company focused on novel treatments for rare

Related Keywords

,Paul Michaels ,Steve Chizzik ,Boca Raton ,Development Agreement ,Securities Exchange ,Michaels ,Curative Biotechnology Inc ,Investigational New Drug ,Toxicology Study ,Topical Instillation ,Curative Biotechnology ,Intermediate Dry Age Related Macular Degeneration ,Geographical Atrophy ,Cooperative Research ,National Eye Institute ,National Institutes ,Bethesda Maryland ,Macular Degeneration ,Geographic Atrophy ,Curative Biotech ,Age Related Macular Degeneration ,Securities Act ,Securities Exchange Act ,Curative ,Biotechnology ,Nnounces ,Completion ,Nabling ,Eformulated ,Metformin ,Drop ,Study ,